These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 946336

  • 1. [Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis].
    Cendrowski W.
    Wiad Lek; 1976 Feb 01; 29(3):193-6. PubMed ID: 946336
    [No Abstract] [Full Text] [Related]

  • 2. [Methylprednisolone acetate in intrathecal administration in multiple sclerosis].
    Palchetti R, Giunta A, Tortoli V, Scarpelli PT.
    Rass Neurol Veg; 1965 Jun 30; 19(3):243-8. PubMed ID: 5899668
    [No Abstract] [Full Text] [Related]

  • 3. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.
    Baker AG.
    Ann Allergy; 1967 Dec 30; 25(12):665-72. PubMed ID: 6072742
    [No Abstract] [Full Text] [Related]

  • 4. [Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis].
    Delzanno GB, Jann G.
    Clin Ter; 1969 Jan 31; 48(2):151-5. PubMed ID: 5409031
    [No Abstract] [Full Text] [Related]

  • 5. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P, Kupka J, Kocinová F.
    Cesk Neurol Neurochir; 1975 Dec 31; 38(6):338-45. PubMed ID: 1104205
    [No Abstract] [Full Text] [Related]

  • 6. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V, Girelli Bruni E, Monaco V, Gasperini GF, Zardini GB, Brogi L.
    Minerva Med; 1974 Sep 19; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract] [Full Text] [Related]

  • 7. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.
    Goldstein NP, McGuckin WF, McKenzie BF, Mattox VR.
    Trans Am Neurol Assoc; 1970 Sep 19; 95():243-4. PubMed ID: 5537958
    [No Abstract] [Full Text] [Related]

  • 8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L, Zouhar A.
    Cesk Neurol Neurochir; 1974 Sep 19; 37(5):287-92. PubMed ID: 4479028
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study.
    Beck RH.
    J Am Osteopath Assoc; 1967 Feb 19; 66(6):664-6. PubMed ID: 5182604
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL, Mandzjuk B, Skálová M.
    Cesk Neurol Neurochir; 1974 Sep 19; 37(5):293-300. PubMed ID: 4479029
    [No Abstract] [Full Text] [Related]

  • 13. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P, Poloni M, Piccolo G, Cosi V, Pinelli P.
    Acta Neurol Belg; 1983 Sep 19; 83(4):190-6. PubMed ID: 6689244
    [Abstract] [Full Text] [Related]

  • 14. [Meningitis after intrathecal administration of corticosteroids].
    Schock G, Wieczorek V.
    Psychiatr Neurol Med Psychol (Leipz); 1974 Aug 19; 26(8):477-9. PubMed ID: 4480094
    [No Abstract] [Full Text] [Related]

  • 15. Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study.
    De Vito SJ, Mannarelli AA.
    J Am Osteopath Assoc; 1966 Mar 19; 65(7):713-22. PubMed ID: 5175985
    [No Abstract] [Full Text] [Related]

  • 16. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.
    Abel R, Nelson DA, Bernat JL.
    Del Med J; 1977 Jun 19; 49(6):331-43. PubMed ID: 577483
    [No Abstract] [Full Text] [Related]

  • 17. The management of the multiple sclerosis patient.
    Boines GJ.
    Behav Neuropsychiatry; 1969 Jun 19; 1(3):29-32. PubMed ID: 5408861
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Sellebjerg F.
    Dan Med Bull; 2004 May 19; 51(2):167-83. PubMed ID: 16009055
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.